Safety, Tolerability and Preliminary Efficacy of 161Tb-LNC1011 (PSMA Radioligand) in Patients With Metastatic Castration-Resistant Prostate Cancer (mCRPC)
Clinical trial NCT07381582 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07381582
- Sponsor
- Peking Union Medical College Hospital
- Status
- NOT_YET_RECRUITING
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2026-01-01
- Primary completion
- 2027-10-31
- Enrollment
- 15
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.